| Myelodysplastic Syndrome with Low Blasts studied in …STUDIED_INderived10 of 23show all (up to 200) |
|---|
| → studied in | NCT04869683NA · recruiting Biocollection in MyeloDysplastic Syndrome (P-MDS) · condition mapped ALIAS · 23 trials mapped (1 active) | — | — | Myelodysplastic Syndrome with del(5q) | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01869114Phase 2 · completed Sirolimus and Azacitidine in Treating Patients With High Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia That is Recurrent or Not Eligible for Intensive Chemotherapy · condition mapped ALIAS · 23 trials mapped (1 active) | — | — | Myelodysplastic Syndrome with del(5q) | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02566304Phase 2 · completed Reduced Intensity Chemotherapy and Radiation Therapy Before Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies · condition mapped ALIAS · 23 trials mapped (1 active) | — | — | Myelodysplastic Syndrome, Not Otherwise Specified with Multilineage Dysplasia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00589316Phase 1 · terminated Iodine I 131 Monoclonal Antibody BC8, Fludarabine Phosphate, Cyclophosphamide, Total-Body Irradiation and Donor Bone Marrow Transplant in Treating Patients With Advanced Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or High-Risk Myelodysplastic Syndrome · condition mapped ALIAS · 23 trials mapped (1 active) | — | — | Myelodysplastic Syndrome, Not Otherwise Specified with Multilineage Dysplasia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00119366Phase 2 · terminated Iodine I 131 Monoclonal Antibody BC8, Fludarabine Phosphate, Total Body Irradiation, and Donor Stem Cell Transplant Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients With Advanced Acute Myeloid Leukemia or Myelodysplastic Syndrome · condition mapped ALIAS · 23 trials mapped (1 active) | — | — | Myelodysplastic Syndrome, Not Otherwise Specified with Multilineage Dysplasia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04701229unknown Haploinsufficiency of the RBM22 and SLU7 Genes in Del(5q) Myelodysplastic Syndromes · condition mapped ALIAS · 23 trials mapped (1 active) | — | — | Myelodysplastic Syndrome with del(5q) | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00397813Phase 2 · completed Fludarabine Phosphate and Total Body Irradiation Followed by a Donor Peripheral Stem Cell Transplant in Treating Patients With Myelodysplastic Syndromes or Myeloproliferative Disorders · condition mapped ALIAS · 23 trials mapped (1 active) | — | — | Myelodysplastic Syndrome, Not Otherwise Specified with Multilineage Dysplasia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01012492Phase 2 · completed Pilot of Abatacept-based Immunosuppression for Prevention of Acute GvHD During Unrelated Donor HCT · condition mapped ALIAS · 23 trials mapped (1 active) | — | — | Myelodysplastic Syndrome, Not Otherwise Specified with Multilineage Dysplasia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00008177Phase 1 · completed Radiolabeled Monoclonal Antibody Therapy, Fludarabine Phosphate, and Low-Dose Total-Body Irradiation Followed by Donor Stem Cell Transplant and Immunosuppression Therapy in Treating Older Patients With Advanced Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes · condition mapped ALIAS · 23 trials mapped (1 active) | — | — | Myelodysplastic Syndrome, Not Otherwise Specified with Multilineage Dysplasia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02666950Phase 2 · completed WEE1 Inhibitor AZD1775 With or Without Cytarabine in Treating Patients With Advanced Acute Myeloid Leukemia or Myelodysplastic Syndrome · condition mapped ALIAS · 23 trials mapped (1 active) | — | — | Myelodysplastic Syndrome with del(5q) | 1 | Observed | clinicaltrials | graph → |